Bath & Body Works (NYSE:BBWI) PT Raised to $45.00 at Piper Sandler

Bath & Body Works (NYSE:BBWI) had its price target increased by research analysts at Piper Sandler from $44.00 to $45.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Piper Sandler’s target price would indicate a potential downside of 0.82% from the stock’s previous close.

A number of other research firms have also recently weighed in on BBWI. Evercore ISI boosted their target price on shares of Bath & Body Works from $30.00 to $45.00 and gave the stock an “in-line” rating in a research note on Friday, March 1st. Telsey Advisory Group reissued an “outperform” rating and issued a $53.00 price objective on shares of Bath & Body Works in a research note on Friday, April 5th. Robert W. Baird boosted their price objective on shares of Bath & Body Works from $50.00 to $54.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. Barclays cut shares of Bath & Body Works from an “overweight” rating to an “equal weight” rating and boosted their price objective for the stock from $37.00 to $45.00 in a research note on Thursday, January 4th. Finally, TD Cowen boosted their price objective on shares of Bath & Body Works from $35.00 to $55.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $46.33.

Bath & Body Works Stock Performance

NYSE BBWI opened at $45.37 on Tuesday. The firm’s fifty day moving average price is $46.06 and its two-hundred day moving average price is $39.57. The stock has a market cap of $10.20 billion, a PE ratio of 11.78, a PEG ratio of 1.52 and a beta of 1.86. Bath & Body Works has a fifty-two week low of $27.30 and a fifty-two week high of $50.34.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.21. The firm had revenue of $2.91 billion for the quarter, compared to analysts’ expectations of $2.84 billion. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The company’s revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.86 earnings per share. As a group, sell-side analysts predict that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of the firm’s stock in a transaction on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total value of $209,493.65. Following the sale, the insider now owns 45,992 shares of the company’s stock, valued at approximately $2,248,548.88. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.19% of the company’s stock.

Institutional Investors Weigh In On Bath & Body Works

Large investors have recently added to or reduced their stakes in the company. Denali Advisors LLC bought a new stake in shares of Bath & Body Works during the 4th quarter valued at about $27,000. GAMMA Investing LLC bought a new stake in shares of Bath & Body Works during the 4th quarter valued at about $27,000. Money Concepts Capital Corp boosted its stake in shares of Bath & Body Works by 1,180.4% during the 4th quarter. Money Concepts Capital Corp now owns 653 shares of the company’s stock valued at $28,000 after purchasing an additional 602 shares in the last quarter. Front Row Advisors LLC bought a new stake in shares of Bath & Body Works during the 3rd quarter valued at about $25,000. Finally, Trust Co. of Vermont bought a new stake in shares of Bath & Body Works during the 3rd quarter valued at about $27,000. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.